We are live on
!
Find out more
Boston Trust Walden Portfolio holdings
AUM
$13.1B
Turnover
6.42%
1-Year Est. Return
24.63%
This Fund
S&P 500
This Quarter
Est. Return
+3.74%
1 Year Est. Return
+24.63%
3 Year Est. Return
+61.41%
5 Year Est. Return
+82.17%
10 Year Est. Return
+348.29%
AUM
$6.22B
AUM Growth
-$194M
(-3%)
Cap. Flow
-$367M
Cap. Flow
% of AUM
-5.9%
Top 10 Holdings %
Top 10 Hldgs %
16.53%
Holding
380
New
29
Increased
159
Reduced
150
Closed
10
Avg Time Held
2.8
years
Top 10 Avg Time Held
1.2
years
Top 20 Avg Time Held
2.1
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alphabet (Google) Class C
GOOG
|
+$18M |
| 2 |
Monro
MNRO
|
+$15.1M |
| 3 |
Dentsply Sirona
XRAY
|
+$14.8M |
| 4 |
Hubbell
HUBB
|
+$12.1M |
| 5 |
Northern Trust
NTRS
|
+$8.96M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
BCR
CR Bard Inc.
BCR
|
+$31.3M |
| 2 |
W.W. Grainger
GWW
|
+$26.8M |
| 3 |
Verizon
VZ
|
+$21.9M |
| 4 |
IPG Photonics
IPGP
|
+$18.2M |
| 5 |
Coherent Inc
COHR
|
+$16.3M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 19.36% |
| 2 | Healthcare | 17.82% |
| 3 | Technology | 14.53% |
| 4 | Industrials | 13.36% |
| 5 | Consumer Discretionary | 9.58% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
151
Oceaneering
OII
$4.28B
| $12.1M | 0.19% |
530,013
-210,238
| -28% | -$5.35M |
2013 Q2
16 quarters
|
|
152
Advance Auto Parts
AAP
$2.65B
| $12.1M | 0.19% |
103,471
-47,185
| -31% | -$6.48M |
2013 Q2
16 quarters
|
|
153
Wabtec
WAB
$48.6B
| $12M | 0.19% |
131,118
+6,500
| +5% | +$542K |
2013 Q2
16 quarters
|
|
154
Haemonetics
HAE
$5.52B
| $11.8M | 0.19% |
299,597
-89,021
| -23% | -$3.66M |
2013 Q2
16 quarters
|
|
155
Amdocs
DOX
$6.34B
| $11.7M | 0.19% |
182,105
+19,781
| +12% | +$1.25M |
2016 Q1
5 quarters
|
|
156
Factset
FDS
$10.7B
| $11.5M | 0.19% |
69,500
+20,825
| +43% | +$3.41M |
2013 Q2
16 quarters
|
|
157
Jones Lang LaSalle
JLL
$14.3B
| $11.5M | 0.19% |
92,383
+3,046
| +3% | +$350K |
2013 Q2
16 quarters
|
|
158
Cooper Companies
COO
$10.9B
| $11.5M | 0.19% |
192,544
+6,960
| +4% | +$378K |
2014 Q1
13 quarters
|
|
159
Quaker Houghton
KWR
$2.73B
| $11.4M | 0.18% |
78,793
-23,369
| -23% | -$3.31M |
2013 Q2
16 quarters
|
|
160
DELISTED
Meridian Bioscience Inc
VIVO
| $11.2M | 0.18% |
709,363
-226,227
| -24% | -$3.26M |
2015 Q4
6 quarters
|
|
161
Edwards Lifesciences
EW
$50.8B
| $11.1M | 0.18% |
282,450
| – | – |
2013 Q2
16 quarters
|
|
|
WFM
162
DELISTED
Whole Foods Market Inc
WFM
| $11.1M | 0.18% |
263,103
-268
| -0.1% | -$9.76K |
2014 Q3
11 quarters
|
|
163
F5
FFIV
$25.9B
| $10.9M | 0.18% |
85,968
+2,858
| +3% | +$374K |
2013 Q2
16 quarters
|
|
164
Eagle Bancorp
EGBN
$854M
| $10.9M | 0.17% |
171,972
-50,579
| -23% | -$3.02M |
2013 Q4
14 quarters
|
|
165
WEX
WEX
$6.17B
| $10.9M | 0.17% |
104,371
-30,714
| -23% | -$3.16M |
2013 Q2
16 quarters
|
|
|
SBNY
166
DELISTED
Signature Bank
SBNY
| $10.8M | 0.17% |
75,543
+2,299
| +3% | +$326K |
2013 Q2
16 quarters
|
|
167
Artisan Partners
APAM
$2.33B
| $10.8M | 0.17% |
352,156
-188,120
| -35% | -$5.41M |
2013 Q2
16 quarters
|
|
168
SLB Ltd
SLB
$71.8B
| $10.8M | 0.17% |
164,041
-7,454
| -4% | -$534K |
2013 Q2
16 quarters
|
|
169
American Financial Group
AFG
$12.1B
| $10.7M | 0.17% |
108,162
+3,058
| +3% | +$299K |
2016 Q2
4 quarters
|
|
170
The Ensign Group
ENSG
$10.4B
| $10.7M | 0.17% |
525,433
-163,950
| -24% | -$2.98M |
2015 Q3
7 quarters
|
|
171
DELISTED
Atrion Corp
ATRI
| $10.7M | 0.17% |
16,632
-5,397
| -24% | -$2.9M |
2015 Q2
8 quarters
|
|
172
Avery Dennison
AVY
$13.3B
| $10.2M | 0.16% |
115,180
+3,196
| +3% | +$268K |
2015 Q3
7 quarters
|
|
173
Tompkins Financial
TMP
$1.4B
| $10M | 0.16% |
127,367
-7,520
| -6% | -$606K |
2014 Q2
12 quarters
|
|
174
Diageo
DEO
$52.3B
| $9.77M | 0.16% |
81,526
+2,111
| +3% | +$251K |
2013 Q2
16 quarters
|
|
175
MillerKnoll
MLKN
$1.49B
| $9.64M | 0.15% |
316,963
-94,411
| -23% | -$3.01M |
2013 Q2
16 quarters
|
|
Similar funds
Boston Trust Walden's Q2 2017 Portfolio in Review
As of Q2 2017, Boston Trust Walden held 380 positions worth $6.22B, down 3% from $6.42B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
Boston Trust Walden withdrew a net $367M in Q2 2017, closing 10 positions and reducing 150 holdings. Its most notable exit was Air Methods Corp, an estimated $15.4M position sold in full.
By sector, the portfolio is most concentrated in Financials at 19% of assets, up from 19% a quarter earlier, followed by Healthcare and Technology.
Against the trend, Boston Trust Walden opened a new position in Monro worth $12.7M.
- Boston Trust Walden's largest Q2 2017 buy was Monro: 303,868 shares worth $12.7M.
- Boston Trust Walden added most to Alphabet (Google) Class C in Q2 2017, an estimated $18M increase.
- Boston Trust Walden's biggest Q2 2017 reduction was CR Bard Inc., cutting an estimated $31.3M.
- Boston Trust Walden fully exited Air Methods Corp in Q2 2017, selling an estimated $15.4M.
- Boston Trust Walden's ten largest holdings make up 17% of its $6.22B portfolio in Q2 2017.
- Boston Trust Walden opened 29 new positions and closed 10 in Q2 2017.
- Boston Trust Walden's portfolio value fell 3% quarter-over-quarter to $6.22B.
Based on Boston Trust Walden's 13F filing for Q2 2017, filed 19 Jul 2017.